Zoetis Inc. (NYSE:ZTS) EVP Roxanne Lagano Sells 652 Shares

Zoetis Inc. (NYSE:ZTS - Get Free Report) EVP Roxanne Lagano sold 652 shares of the business's stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total value of $110,840.00. Following the completion of the sale, the executive vice president now owns 15,129 shares of the company's stock, valued at $2,571,930. The trade was a 4.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Roxanne Lagano also recently made the following trade(s):

• On Monday, March 10th, Roxanne Lagano sold 326 shares of Zoetis stock. The stock was sold at an average price of $170.00, for a total value of $55,420.00.

Zoetis Stock Performance

ZTS stock traded up $1.54 during trading on Friday, hitting $170.15. The company had a trading volume of 1,505,404 shares, compared to its average volume of 2,539,913. The firm has a market cap of $75.75 billion, a PE ratio of 31.11, a price-to-earnings-growth ratio of 2.78 and a beta of 0.94. Zoetis Inc. has a 1-year low of $139.70 and a 1-year high of $200.33. The firm has a 50-day moving average price of $157.41 and a 200-day moving average price of $164.21. The company has a quick ratio of 1.08, a current ratio of 1.75 and a debt-to-equity ratio of 1.09.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.40 by $0.08. Zoetis had a return on equity of 53.82% and a net margin of 26.86%. The business had revenue of $2.22 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same quarter in the previous year, the company earned $1.38 EPS. The company's quarterly revenue was up 1.4% on a year-over-year basis. On average, analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 3rd. Investors of record on Friday, July 18th will be issued a $0.50 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.00 annualized dividend and a yield of 1.18%. Zoetis's dividend payout ratio is currently 35.91%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on ZTS shares. Piper Sandler upped their price target on Zoetis from $205.00 to $210.00 and gave the company an "overweight" rating in a report on Monday, May 12th. Morgan Stanley cut their target price on Zoetis from $243.00 to $238.00 and set an "overweight" rating for the company in a research report on Friday, February 14th. UBS Group cut their price target on Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a report on Wednesday, May 7th. Barclays raised their price objective on Zoetis from $242.00 to $244.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. Finally, Stifel Nicolaus decreased their price target on Zoetis from $180.00 to $165.00 and set a "buy" rating for the company in a research note on Monday, April 14th. One investment analyst has rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and a consensus price target of $212.75.

Hedge Funds Weigh In On Zoetis

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Callahan Advisors LLC lifted its holdings in Zoetis by 90.4% in the fourth quarter. Callahan Advisors LLC now owns 13,105 shares of the company's stock worth $2,135,000 after acquiring an additional 6,221 shares during the last quarter. CIBC Asset Management Inc grew its position in Zoetis by 24.1% in the fourth quarter. CIBC Asset Management Inc now owns 237,369 shares of the company's stock worth $38,617,000 after buying an additional 46,050 shares during the last quarter. Schroder Investment Management Group raised its holdings in Zoetis by 2.6% during the fourth quarter. Schroder Investment Management Group now owns 245,726 shares of the company's stock valued at $40,036,000 after buying an additional 6,169 shares in the last quarter. Vanguard Group Inc. lifted its position in Zoetis by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 41,366,877 shares of the company's stock worth $6,739,905,000 after acquiring an additional 120,158 shares during the last quarter. Finally, Alberta Investment Management Corp lifted its position in Zoetis by 2,050.0% during the 4th quarter. Alberta Investment Management Corp now owns 30,100 shares of the company's stock worth $4,904,000 after acquiring an additional 28,700 shares during the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.